Kirk Calhoun

Kirk K.
Calhoun is Lead Director at NeuroSigma, Inc. Mr. Calhoun is Independent Director at NantHealth, Inc. since 2016.
Mr. Calhoun is Director at Afaxys, Inc. Mr. Calhoun is Member at The American Institute of Certified Public Accountants.
Mr. Calhoun is Member-Governors Board at California State University Foundation since 2000.
Mr. Calhoun is Member at National Association of Corporate Directors (Virginia).
Mr. Calhoun is Member at California Society of Certified Public Accountants.
Former roles include Director at American Pharmaceutical Partners, Inc., Director at Gilead Colorado, Inc., Director at Replidyne, Inc. from 2006 to 2009, Director at PLx Pharma, Inc., Director at Aspreva Pharmaceuticals Corp.
from 2004 to 2008, Director at Adams Respiratory Therapeutics, Inc. from 2005 to 2008, Lead Independent Director at Response Genetics, Inc. from 2012 to 2015, Director at Abraxis BioScience, Inc. from 2002 to 2007 and from 2007 to 2010, Independent Director at Great Basin Scientific, Inc. from 2015 to 2017, Independent Director at Ryerson Holding Corp.
from 2014 to 2026, Director at NeuroGeneration, Inc., Director at Western Filter Corp., Independent Director at PLx Pharma, Inc., and Partner at Ernst & Young LLP from 1975 to 2002.
Education includes undergraduate degree from the University of Southern California.